Efficacy and Safety of Fingolimod in an Unselected Patient Population
Fig 4
Mean difference of IFNgamma expression between baseline and three months under fingolimod treatment in responders and non-responders.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Mean difference of IFNgamma expression between baseline and three months under fingolimod treatment in responders and non-responders.